Test Price
2,800 AED✅ Home Collection Available
SDHA Gene Paragangliomas Type 5 Genetic Test – NGS Sequencing in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SDHA Gene Paragangliomas Type 5 Next‑Generation Sequencing (NGS) Genetic Test screens the entire coding region of the SDHA tumor suppressor gene to identify pathogenic variants causative of hereditary paraganglioma‑pheochromocytoma syndrome type 5. This UAE‑optimized, ISO 9001:2015‑certified assay delivers definitive risk stratification and familial screening guidance within 3–4 weeks from a simple blood draw, extracted DNA, or a single drop of blood on an FTA card.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full coding region, copy number analysis | Single‑gene Sanger sequencing – limited to predefined exons, no large deletion/duplication detection |
| Diagnostic Sensitivity | 99.9% for all variant types (SNVs, indels, CNVs) | ~85% – misses deep intronic and copy‑number changes |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| UAE Regulatory Alignment | Fully compliant with Federal Decree‑Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of ICT in Health Fields | May lack locally audited consent and data privacy protocols |
Physician Insight & Safety Protocols
“Genetic testing for SDHA can provide critical insights into hereditary risk. Our team ensures every result is interpreted within your personal and family medical history. Even a negative result does not eliminate all risk, so regular surveillance remains important. We are here to guide you through every step.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Medication Advisory
Important:
Do not discontinue prescribed medication without consulting your doctor. Changes to medication should only be made under medical supervision.
Safety & Exclusion Criteria
- Pre‑test Requirement: A formal genetic counselling session and documented clinical history are mandatory before sample collection.
- Minors: Testing of individuals under 18 years requires explicit written guardian consent as per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Sample Integrity: Recent blood transfusion or active infection may compromise DNA quality; reschedule collection if applicable.
- Emergency Red Flags: If you develop sudden severe headache, palpitations, sweating, or dangerously high blood pressure, seek emergency medical care immediately – these may indicate a catecholamine‑secreting tumour crisis.
Patient FAQ & Clinical Guidance
1. What is the SDHA Gene Paragangliomas Type 5 Genetic Test, and who should consider it?
Direct Answer: This next‑generation sequencing test detects SDHA mutations to confirm hereditary paraganglioma‑pheochromocytoma syndrome and guide family screening.
The test examines the entire SDHA gene for inherited changes that cause paraganglioma type 5. It is recommended for individuals with a personal or family history of paragangliomas, pheochromocytomas, gastrointestinal stromal tumours, or renal cell carcinoma, as well as asymptomatic at‑risk relatives of a known mutation carrier. Genetic counselling is integrated to help you understand the implications and next steps.
2. How is the sample collected, and what logistics are available in the UAE?
Direct Answer: You can choose between a hospital‑grade home phlebotomy visit, submission of previously extracted DNA, or a simple finger‑prick blood drop on an FTA card.
Our VIP mobile phlebotomy service operates from 8 AM to 11 PM, using ISO‑certified cold‑chain transport to preserve sample integrity. A trained phlebotomist arrives at your doorstep; the procedure takes under 10 minutes. Payment and insurance verification are handled seamlessly via WhatsApp before the visit. All personal health data is protected under the UAE PDPL and Federal Law No. 2 of 2019.
3. What should I do after receiving my results, and how is follow‑up managed?
Direct Answer: Our clinical team provides a telephonic interpretation session to explain the result, its impact, and recommended surveillance or preventive measures.
A positive result means a heightened risk and may trigger screening for other family members; we coordinate cascade testing with full confidentiality. A negative result in a known family mutation brings substantial reassurance. Regardless of outcome, we schedule a follow‑up consultation with the ordering oncologist or clinical geneticist. You will receive a structured, written report aligned with DHA guidelines.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
This test fully complies with UAE data protection and health data security frameworks:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensures secure handling of your health information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governs digital health data and telemedicine.
- Patient Consent under Federal Decree‑Law No. 4 of 2016 on Medical Liability – all procedures require documented informed consent.
Your data is encrypted, stored locally in the UAE, and accessible only to authorized medical personnel. We adhere to DHA‑mandated data retention and disposal policies.
Clinical & Logistical Metadata
| Test Name | SDHA Gene Paragangliomas Type 5 Genetic Test (NGS Sequencing) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card Blood Spot |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Coding Region & Copy Number Analysis |
| ICD-10-CM Code | D44.6 (Paraganglioma, unspecified), Z15.0 (Genetic susceptibility) |
| LOINC Code | 59041-2 (SDHA gene mutation analysis) |
| DHA Facility License & Laboratory Address | DNA Labs UAE – DHA License No. 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians